Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Vivani Medical Inc.

Start price
Target price
Perf. (%)
€26.55
10.03.21
-
10.03.22
-86.89%
11.03.22

Lower EBIT Margin than peer group
High valuation
Low dividend yield expected
negative Cash Flow expected
PerkinElmer Inc.

Start price
Target price
Perf. (%)
€160.00
09.09.21
-
09.09.22
-2.97%
10.03.22

Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
buy
Agilent Technologies Inc.

Start price
Target price
Perf. (%)
€101.00
09.03.21
€120.00
09.03.22
19.46%
10.03.22

Could be worthwhile Investment >10% per year
Drägerwerk AG & Co. KGaA VZO

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-21.91%
09.03.22

buy
Drägerwerk AG & Co. KGaA ST

Start price
Target price
Perf. (%)
€61.80
08.03.21
-
08.03.22
-26.29%
09.03.22

Orpea Nom.

Start price
Target price
Perf. (%)
€36.36
19.02.22
€32.00
19.02.23
-5.42%
05.03.22

Risky Investment
buy
Dexcom Inc.

Start price
Target price
Perf. (%)
€125.40
30.11.21
-
30.11.22
-27.01%
02.03.22

buy
Harvard Bioscience

Start price
Target price
Perf. (%)
€6.50
27.07.21
-
27.07.22
-25.54%
02.03.22

buy
Castlight Healt.b

Start price
Target price
Perf. (%)
€1.85
23.07.21
-
23.07.22
-4.32%
02.03.22

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€57.94
01.03.21
-
01.03.22
-2.93%
02.03.22

buy
Vita 34 AG

Start price
Target price
Perf. (%)
€15.55
21.02.21
-
21.02.22
-25.08%
22.02.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
Orpea Nom.

Start price
Target price
Perf. (%)
€34.38
06.02.22
€31.00
06.02.23
5.76%
19.02.22

Risky Investment
buy
EssilorLuxottica SA

Start price
Target price
Perf. (%)
€155.60
08.07.21
€195.00
08.07.22
8.64%
18.02.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Future proof or reliable business model
buy
Spineway

Start price
Target price
Perf. (%)
€68.00
15.06.21
-
15.06.22
-52.94%
16.02.22

Could be very worthwhile Investment >20% year
Market Leader or Top 3
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€36.24
01.02.21
€40.00
01.02.22
1.56%
01.02.22

Teladoc Health Inc

Start price
Target price
Perf. (%)
€60.46
24.01.22
€52.00
24.01.23
5.86%
30.01.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€225.60
24.01.22
€210.00
24.01.23
9.44%
30.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€38.44
27.01.21
€45.00
27.01.22
-4.29%
28.01.22

Could be worthwhile Investment >10% per year
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€240.00
25.01.21
€350.00
25.01.22
-73.33%
26.01.22

Could be very worthwhile Investment >20% year
buy
Intuitive Surgical Inc

Start price
Target price
Perf. (%)
€304.50
13.12.21
€330.00
13.12.22
-25.91%
24.01.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
buy
Teladoc Health Inc

Start price
Target price
Perf. (%)
€75.84
11.01.22
€82.00
11.01.23
-20.28%
24.01.22

Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
buy
Visiomed Group

Start price
Target price
Perf. (%)
€0.86
25.01.21
€1.00
25.01.22
-80.01%
24.01.22

Could be worthwhile Investment >10% per year
buy
Atossa Genetics Inc

Start price
Target price
Perf. (%)
€1.85
23.01.21
€60.00
23.01.22
-41.51%
24.01.22

Could be very worthwhile Investment >20% year
buy
Star Equity Holdings Inc.

Start price
Target price
Perf. (%)
€3.16
23.01.21
€30.00
23.01.22
-67.09%
24.01.22

Could be very worthwhile Investment >20% year
buy
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€35.75
23.01.21
-
23.01.22
-73.67%
24.01.22

Could be very worthwhile Investment >20% year